Paper40417828
rLVS ΔcapB/Yp F1-V single vector platform vaccine expressing Yersinia pestis F1 and LcrV antigens provides complete protection against lethal respiratory challenge with virulent plague bacilli.
Jia Q and 3 others. Hum Vaccin Immunother, 2025. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. rLVS ΔcapB/Yp F1-V single vector platform vaccine expressing Yersinia pestis F1 and LcrV antigens provides complete protection against lethal respiratory challenge with virulent plague bacilli. Papers, record 40417828. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40417828
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- rLVS ΔcapB/Yp F1-V single vector platform vaccine expressing Yersinia pestis F1 and LcrV antigens provides complete protection against lethal respiratory challenge with virulent plague bacilli.
- PubMed
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Plague | Major topic |
| Plague Vaccine | Major topic |
| Pore Forming Cytotoxic Proteins | Major topic |
| Yersinia pestis | Major topic |
| Antigens, Bacterial | Major topic |
| Bacterial Proteins | Major topic |
| Fimbriae Proteins | Major topic |
| Animals | |
| Vaccines, Attenuated | |
| Female | |
| Antibodies, Bacterial | |
| Vaccines, Synthetic | |
| Mice | |
| Mice, Inbred BALB C | |
| Disease Models, Animal | |
| Immunization, Secondary | |
| Genetic Vectors | |
| Survival Analysis | |
| Francisella tularensis |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R01 AI141390 | NIAID NIH HHS | United States | R01AI141390 | PubMed and NIH |
Source NIH RePORTER
References31
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15574954 | Construction and characterization of a highly efficient Francisella shuttle plasmid. | Appl Environ Microbiol | 2004 | https://conductscience.org/library/papers/15574954 | PubMed |
| 2 | 27722869 | Plague Vaccines: Status and Future. | Adv Exp Med Biol | 2016 | https://conductscience.org/library/papers/27722869 | PubMed |
| 3 | 33514747 | A new generation needle- and adjuvant-free trivalent plague vaccine utilizing adenovirus-5 nanoparticle platform. | NPJ Vaccines | 2021 | https://conductscience.org/library/papers/33514747 | PubMed |
| 4 | 39242587 | Progress on the research and development of plague vaccines with a call to action. | NPJ Vaccines | 2024 | https://conductscience.org/library/papers/39242587 | PubMed |
| 5 | 27170642 | A Replication-Defective Human Type 5 Adenovirus-Based Trivalent Vaccine Confers Complete Protection against Plague in Mice and Nonhuman Primates. | Clin Vaccine Immunol | 2016 | https://conductscience.org/library/papers/27170642 | PubMed |
| 6 | 8578841 | A comparison of Plague vaccine, USP and EV76 vaccine induced protection against Yersinia pestis in a murine model. | Vaccine | 1995 | https://conductscience.org/library/papers/8578841 | PubMed |
| 7 | 8890210 | Recombinant V antigen protects mice against pneumonic and bubonic plague caused by F1-capsule-positive and -negative strains of Yersinia pestis. | Infect Immun | 1996 | https://conductscience.org/library/papers/8890210 | PubMed |
| 8 | 29725025 | Single vector platform vaccine protects against lethal respiratory challenge with Tier 1 select agents of anthrax, plague, and tularemia. | Sci Rep | 2018 | https://conductscience.org/library/papers/29725025 | PubMed |
| 9 | 8675324 | Fraction 1 capsular antigen (F1) purification from Yersinia pestis CO92 and from an Escherichia coli recombinant strain and efficacy against lethal plague challenge. | Infect Immun | 1996 | https://conductscience.org/library/papers/8675324 | PubMed |
| 10 | 15978133 | Immunization of mice with YscF provides protection from Yersinia pestis infections. | BMC Microbiol | 2005 | https://conductscience.org/library/papers/15978133 | PubMed |
| 11 | 21763383 | Prevention of pneumonic plague in mice, rats, guinea pigs and non-human primates with clinical grade rV10, rV10-2 or F1-V vaccines. | Vaccine | 2011 | https://conductscience.org/library/papers/21763383 | PubMed |
| 12 | 18347051 | Yersinia pestis caf1 variants and the limits of plague vaccine protection. | Infect Immun | 2008 | https://conductscience.org/library/papers/18347051 | PubMed |
| 13 | 21193666 | Identification and characterization of novel and potent transcription promoters of Francisella tularensis. | Appl Environ Microbiol | 2011 | https://conductscience.org/library/papers/21193666 | PubMed |
| 14 | 23439306 | A heterologous prime-boost vaccination strategy comprising the Francisella tularensis live vaccine strain capB mutant and recombinant attenuated Listeria monocytogenes expressing F. tularensis IglC induces potent protective immunity in mice against virulent F. tularensis aerosol challenge. | Infect Immun | 2013 | https://conductscience.org/library/papers/23439306 | PubMed |
| 15 | 37975637 | The rLVS ΔcapB/iglABC vaccine provides potent protection in Fischer rats against inhalational tularemia caused by various virulent Francisella tularensis strains. | Hum Vaccin Immunother | 2023 | https://conductscience.org/library/papers/37975637 | PubMed |
| 16 | 9281474 | Expression of an F1/V fusion protein in attenuated Salmonella typhimurium and protection of mice against plague. | Microb Pathog | 1997 | https://conductscience.org/library/papers/9281474 | PubMed |
| 17 | 16987180 | Type IV pili-mediated secretion modulates Francisella virulence. | Mol Microbiol | 2006 | https://conductscience.org/library/papers/16987180 | PubMed |
| 18 | 23853602 | Mutated and bacteriophage T4 nanoparticle arrayed F1-V immunogens from Yersinia pestis as next generation plague vaccines. | PLoS Pathog | 2013 | https://conductscience.org/library/papers/23853602 | PubMed |
| 19 | 36916971 | Oral Administration of Universal Bacterium-Vectored Nucleocapsid-Expressing COVID-19 Vaccine is Efficacious in Hamsters. | Microbiol Spectr | 2023 | https://conductscience.org/library/papers/36916971 | PubMed |
| 20 | 8745007 | A new improved sub-unit vaccine for plague: the basis of protection. | FEMS Immunol Med Microbiol | 1995 | https://conductscience.org/library/papers/8745007 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42964573 | Multi-pathogen and combination vaccines for biodefense pathogens. | Front Immunol | 2026 | https://conductscience.org/library/papers/42964573 | PubMed |
| 42576894 | Anti-infective compounds for Yersinia. | Sustain Microbiol | 2026 | https://conductscience.org/library/papers/42576894 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40417828
GET https://conductscience.org/api/papers/v1/40417828/references?page=2